Pure Global
NCT06349525

Retention of Telescopic Versus Locator Attachments

Retention of Telescopic Versus Locator Attachments And Marginal Bone Loss Surrounding Implants Supporting Maxillary Over-dentures: Two Year Randomized Clinical Trial
Delta University for Science and Technology·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Jaw, Edentulous
Drug/Device/Intervention
telescopic overdenture
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Delta University for Science and Technology
Location
Mansoura, Egypt
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2021
End date
Oct 01, 2023
Enrollment
40 participants
Primary outcome

Retention

Summary

Forty patients ( 24female and16 male )with completely edentulous maxilla and mandible . All
 patients received implant supported mandibular and maxillary overdentures. The patients were
 randomly divided into two groups according to attachments retaining Max IOD that supported by
 four axial implants in maxilla . The TA was used to retain group I (GrI) MaxIOD , while that
 of group II (Gr II) was retained by LA. MaxIOD retention and MBL(vertical and horizontal)
 around implants of both groups was recorded at time of insertion (R0) ,then twelve(R12)and
 (R24) months following insertion of the prosthesis.

ICD-10 classifications
Dislocation of jawMottled teethDisorder of gingiva and edentulous alveolar ridge, unspecifiedOther disorders of gingiva and edentulous alveolar ridgeOther specified disorders of gingiva and edentulous alveolar ridge
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06349525
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06349525 through Pure Global AI's free database. This phase not specified trial is sponsored by Delta University for Science and Technology and is currently Completed. The study focuses on Jaw, Edentulous. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.